Corton Capital »

Kyverna Therapeutics shares owned by Corton Capital

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Corton Capital from 13F filings

Historical chart of Corton Capital investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Corton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Corton Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $45k 12k 3.74

More positions owned by Corton Capital

Shopify Cl A (SHOP)
United Natural Foods (UNFI)
Smith Douglas Homes Corp Com Shs Cl A (SDHC)
Scholastic Corporation (SCHL)
Palantir Technologies Cl A (PLTR)
Bristol Myers Squibb (BMY)
Progressive Corporation (PGR)
Qualcomm (QCOM)
ViaSat (VSAT)
iRobot Corporation (IRBT)
Applied Materials (AMAT)
Vertex Pharmaceuticals Incorporated (VRTX)
Pra (PRAA)
Doordash Cl A (DASH)
Amphenol Corp Cl A (APH)

View all positions for Corton Capital

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Gilead Sciences
Bain Capital Life Sciences Investors
Jpmorgan Chase & Co
Novo A/S
BlackRock
Vanguard Group
Insight Holdings
Millennium Management
Franklin Resources
Mbb Public Markets I
T. Rowe Price Associates
Geode Capital Management
Jacobs Levy Equity Management
State Street Corporation

View all funds holding Kyverna Therapeutics